- Fee assured
- Verified account
- Lower GI
- Upper GI
- Video and telephone consultations
Dr Hill undertook her undergraduate medical training at University College London and the University of Birmingham Medical School. She trained in Oncology in the West Midlands and Oxford deaneries. Prior to completion of her training, she spent time as a Clinical Research Fellow at the Gray Institute of Radiation Oncology and Biology in Oxford, during which she conducted research into the development of imaging to assess the effects of chemotherapy, radiation and novel radiosensitisers on tumour blood flow.
She was appointed as a Consultant Clinical Oncologist at the Royal Berkshire Hospital in Reading and Wexham Park Hospital in Slough, in February 2015. She has a broad range of skills and experience. She is passionate about providing holistic care to patients, tailoring treatment to the individual. She has a sub-specialty interest in the management of upper gastrointestinal cancers and cancers of unknown primary origin, with extensive experience of treating such patients with radiotherapy and systemic therapy. She is a member of the ‘Upper Gastrointestinal Cancer’ Multidisciplinary Teams at both the Royal Berkshire Hospital in Reading and Wexham Park Hospital in Slough; additionally she is a member of the Oxford Oesophago-gastric and Hepato-biliary Multi-disciplinary Teams and has a strong working relationship with the Oxford surgical teams, which enables her to co-ordinate surgical and non-surgical treatments for patients. She has implemented modern radiotherapy techniques such as IMRT and 4DCT for Upper GI cancers and is the clinical lead for SABR treatment of oligometastatic disease at the Royal Berkshire Hospital. She is also the Cancer of Unknown Primary Multi-disciplinary Team Lead at Wexham Park Hospital.
Areas of interest
Cancer of Unknown Primary; Upper GI; Hepatobillary
Current NHS consultant posts held
Consultant Clinical Oncologist, Royal Berkshire Hospital, Reading
King Edward VII Hospital, Windsor
Wexham Park Hospital, Slough.
Outside of medicine Dr Hill enjoys running, gardening and spending time with her family.
Hill, E.J. et al Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer. Clinical Cancer Research; 22(8), 2016
Hill, E.J. et al. Oral nelfinavir before and during radiation therapy for rectal cancer: Changes in tumor perfusion and correlation between tissue and radiological markers of response. Journal of Clinical Oncology, 2014, Vol 32, Supplement 3, 491
Hill EJ, Clift AK, Sharma RA. Principles for Combining Radioembolisation with Systemic Chemotherapy for Metastatic Colorectal Cancer. Interventional Radiology in Cancer, Chapter 14, 2013
Stephanie B Hatch, Lonnie P Swift, Simona Caporali, Rebecca Carter, Esme J Hill, Thomas P MacGregor, Stefania D'Atri, Mark R Middleton, Peter J McHugh and Ricky A Sharma XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection. International Journal of Cancer, 2014; 134(6):1495-503
Adams E, Hill EJ, Watson E. Fertility preservation in cancer survivors: a national survey of oncologists' current knowledge, practice and attitudes. British Journal of Cancer 2013, 108 (8);1602-15
Wang LM, Jani AR, Hill EJ, Sharma RA. Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases. Journal of Clinical Pathology 2013, 66(3), 205-11
Hill EJ, Nicolay NH, Middleton MR, Sharma RA. Oxaliplatin as a radiosensitiser for upper and lower GI tract malignancies: what have we learned from a decade of translational research? Critical Reviews in Oncology & Haematology 2012 83(3): p. 353-87.
Hill EJ, Sharma RA. Multi-modality therapy of hepatic metastases from colorectal carcinoma: optimal combination of systemic chemotherapy with radio-embolization. Journal of Nuclear Medicine &Radiation Therapy 2011; 2: 108
- MBCHb University of Birmingham 2001
- DPhil Radiobiology University of Oxford 2016
- MSc (Oncology) University of London 2006
- MSc (Oncology) Institute of Cancer Research, University of London 2009
- BSc (intercalated) University College of London 1998
- Proton Therapy Clinical Education Programme Penn Medicine 2021
Reference number 6025316
Professional bodies (positions held - last 3 yrs)
- Member Royal College of Physicians 2004
- Fellow Royal College of Radiologists 2009
Details of entry to specialist register
- Clinical Oncology, 2015
- 16 Bath RoadREADINGRG1 6NS
- 16:00 - 19:00
- 0118 955 3531
- 69 Alma RoadWindsorBerkshireSL4 3ES
- 16:00 - 19:00
- 0118 955 3531
- Rutherford Cancer Centre (Thames Valley)
- 16:00 - 18:00
- 0118 955 3531
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.